Medicaid Is Not A Test Lab For Foreign Price Controls
- Bias Rating
- Reliability
65% ReliableAverage
- Policy Leaning
-4% Center
- Politician Portrayal
-1% Negative
Continue For Free
Create your free account to see the in-depth bias analytics and more.
By creating an account, you agree to our Terms and Privacy Policy, and subscribe to email updates.
Bias Score Analysis
The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.
Sentiments
-1% Negative
- Liberal
- Conservative
Sentence | Sentiment | Bias |
---|---|---|
Unlock this feature by upgrading to the Pro plan. |
Reliability Score Analysis
Policy Leaning Analysis
Politician Portrayal Analysis
Bias Meter
Extremely
Liberal
Very
Liberal
Moderately
Liberal
Somewhat Liberal
Center
Somewhat Conservative
Moderately
Conservative
Very
Conservative
Extremely
Conservative
-100%
Liberal
100%
Conservative

Contributing sentiments towards policy:
62% : MFN proponents like to frame the policy as a way to stop "foreign freeloading."58% : Medicaid doesn't need price controls from other countries; it already imposes them here.
57% : Medicaid receives average discounts exceeding 50%.
56% : But we don't have to speculate -- decades of data already show what price controls do to innovation.
53% : The MFN proposal isn't tough on foreign freeloaders.
52% : Rep. Chip Roy, R-Texas, and 19 of his House colleagues have outlined exactly the right approach: restore fiscal responsibility to Medicaid through block grants or per-capita caps, tighten eligibility verification, and align incentives with outcomes.
51% : Instead of doubling down on price controls, Republicans should get serious about structural Medicaid reform.
47% : Under the program's existing "Best Price" rule, manufacturers must offer Medicaid the lowest price they give to any other buyer, plus pay steep, mandatory rebates.
47% : In practice, this could force companies to stop offering their drugs in Medicaid entirely.
47% : It would make Medicaid more expensive, less effective, and more dangerous -- not just to patients, but to the future of American medicine.
46% : In a desperate bid to claim fiscal discipline without touching entitlements, President Donald J. Trump is pushing congressional Republicans to adopt a "most favored nation" (MFN) drug pricing model for Medicaid.
45% : Importing foreign price controls is not a clever budget tactic.
44% : This policy would tie Medicaid reimbursements to the lowest prices paid in other developed countries -- countries where government officials dictate drug prices under threat of coercion, patent confiscation, or market exclusion.
43% : And thanks to federal law, exiting Medicaid also means forfeiting Medicare Part B coverage.
43% : One act of economic illiteracy would therefore sabotage both Medicaid and Medicare simultaneously.
*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.